Your browser doesn't support javascript.
loading
Surgical outcomes and optimal approach to treatment of aortic valve endocarditis with aortic root abscess.
Harris, William M; Sinha, Shubhra; Caputo, Massimo; Angelini, Gianni D; Ahmed, Eltayeb M; Rajakaruna, Cha; Benedetto, Umberto; Vohra, Hunaid A.
Afiliación
  • Harris WM; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Sinha S; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Caputo M; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Angelini GD; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Ahmed EM; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Rajakaruna C; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Benedetto U; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Vohra HA; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
J Card Surg ; 37(7): 1917-1925, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35384049
ABSTRACT

OBJECTIVES:

To evaluate the impact of aortic root abscess (ARA) on the postoperative outcomes of surgically managed infective endocarditis (IE) and to inform optimal surgical approach.

METHODS:

Between 2009 and 2020, 143 consecutive patients who underwent surgical management for aortic-valve IE were included in a retrospective cohort study. Multivariable and propensity-weighted analyses were used to adjust for demographic imbalances between those without (n = 93; NARA) and with an ARA (n = 50). Additionally, empirical subgroup analysis appraised the two most used surgical techniques; patch reconstruction (PR) and aortic root replacement (ARR).

RESULTS:

Demographic characteristics were similar between ARA and NARA except for logistic EuroSCORE, previous valve surgery, and multivalvular infection. In-hospital mortality was 8% and 12% in NARA and ARA, respectively (p = .38), with mortality rates consistently nonsignificantly higher in ARA across all time periods. The overall reoperation rate was also higher in ARA (27% vs. 14%; p = .09) and ARA was shown to be associated with late reoperation (odds ratio [OR] = 2.74; 95% confidence interval [CI] = 1.18-6.36). Patients treated with an ARR showed a 16% increase in late mortality when compared with PR (40% vs. 24%; p = .27) and a 17% lower reoperation rate (14% vs. 31%; p = .24). Propensity-weighted analysis identified ARR as a significant protective factor for reoperation (hazard ratio = 0.05; 95% CI = 0.01-0.34).

CONCLUSIONS:

The presence of an ARA in aortic valve endocarditis was not associated with significantly higher early and late mortality but is linked with a higher reoperation rate at our institution. ARR in ARA is protective from reoperation so should be considered best practice in this setting.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prótesis Valvulares Cardíacas / Implantación de Prótesis de Válvulas Cardíacas / Endocarditis / Endocarditis Bacteriana Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Card Surg Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prótesis Valvulares Cardíacas / Implantación de Prótesis de Válvulas Cardíacas / Endocarditis / Endocarditis Bacteriana Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Card Surg Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido